Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 7 studies | 21% ± 6% | |
connective tissue cell | 4 studies | 33% ± 20% | |
myofibroblast cell | 3 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of P3H4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1125.86 | 328 / 328 | 99% | 37.86 | 177 / 178 |
prostate | 100% | 1363.38 | 245 / 245 | 99% | 37.53 | 499 / 502 |
uterus | 100% | 1501.47 | 170 / 170 | 99% | 51.39 | 456 / 459 |
intestine | 100% | 908.21 | 966 / 966 | 98% | 33.35 | 519 / 527 |
adrenal gland | 100% | 1723.25 | 258 / 258 | 98% | 26.85 | 225 / 230 |
skin | 100% | 1686.54 | 1807 / 1809 | 98% | 42.84 | 462 / 472 |
ovary | 100% | 1187.69 | 180 / 180 | 98% | 30.07 | 420 / 430 |
stomach | 100% | 622.90 | 358 / 359 | 98% | 43.54 | 280 / 286 |
breast | 99% | 769.62 | 454 / 459 | 98% | 42.90 | 1098 / 1118 |
brain | 98% | 730.47 | 2593 / 2642 | 99% | 29.76 | 697 / 705 |
thymus | 100% | 1836.41 | 653 / 653 | 97% | 31.04 | 585 / 605 |
bladder | 100% | 1102.14 | 21 / 21 | 97% | 35.64 | 487 / 504 |
lung | 98% | 915.25 | 568 / 578 | 98% | 41.08 | 1136 / 1155 |
esophagus | 98% | 667.70 | 1417 / 1445 | 97% | 46.25 | 178 / 183 |
kidney | 100% | 1022.10 | 89 / 89 | 92% | 33.04 | 832 / 901 |
liver | 59% | 163.19 | 133 / 226 | 53% | 12.26 | 216 / 406 |
spleen | 100% | 567.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 78.26 | 1 / 1 |
blood vessel | 100% | 1179.33 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 98% | 681.35 | 1178 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 26.80 | 78 / 80 |
heart | 97% | 722.82 | 833 / 861 | 0% | 0 | 0 / 0 |
muscle | 50% | 139.46 | 400 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 34% | 3.66 | 10 / 29 |
peripheral blood | 7% | 17.95 | 67 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030199 | Biological process | collagen fibril organization |
GO_0007130 | Biological process | synaptonemal complex assembly |
GO_0046849 | Biological process | bone remodeling |
GO_0017185 | Biological process | peptidyl-lysine hydroxylation |
GO_0032964 | Biological process | collagen biosynthetic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005730 | Cellular component | nucleolus |
GO_0000794 | Cellular component | condensed nuclear chromosome |
GO_0000795 | Cellular component | synaptonemal complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_1902494 | Cellular component | catalytic complex |
GO_0005518 | Molecular function | collagen binding |
Gene name | P3H4 |
Protein name | Prolyl 3-hydroxylase family member 4 (inactive) Endoplasmic reticulum protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55) (Prolyl 3-hydroxylase family member 4) (Synaptonemal complex protein SC65) |
Synonyms | SC65 NOL55 LEPREL4 |
Description | FUNCTION: Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linking of collagen fibrils. Required for normal bone density and normal skin stability via its role in hydroxylation of lysine residues in collagen alpha chains and in collagen fibril assembly. . |
Accessions | ENST00000592026.1 ENST00000355468.7 Q92791 ENST00000465097.1 K7ERA3 K7EJ03 H0YED7 ENST00000590496.1 ENST00000393928.6 |